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Objectives: NO2 is a major urban air pollutant. Previously reported associations between ambient NO2
and children’s respiratory health have been inconsistent, and independent effects of correlated pollutants
hard to assess. The authors examined effects of NO2 on a spectrum of 11 respiratory symptoms,
controlling for PM10 and SO2, using a large pooled dataset.
Methods: Cross sectional studies were conducted in Russia, Austria, Italy, Switzerland, and the Netherlands,
during 1993–99, contributing in total 23 955 children. Study-specific odds ratios for associations with ambient
NO2 are estimated using logistic regressions with area-level random effects. Heterogeneity between study-
specific results, and mean estimates (allowing for heterogeneity) are calculated.
Results: Long term average NO2 concentrations were unrelated to prevalences of bronchitis or asthma.
Associations were found for sensitivity to inhaled allergens and allergy to pets, with mean odds ratios
around 1.14 per 10 mg/m3 NO2. SO2 had little confounding effect, but an initial association between
NO2 and morning cough was reduced after controlling for PM10. Associations with reported allergy were
not reduced by adjustment for the other pollutants. Odds ratios for allergic symptoms tended to be higher
for the 9–12 year old children compared with the 6–8 year old children.
Conclusions: Evidence for associations between NO2 and respiratory symptoms was robust only for
inhalation allergies. NO2 most likely is acting as an indicator of traffic related air pollutants, though its
direct effect cannot be ruled out. This remains important, as policies to reduce traffic related air pollution
will not result in rapid reductions.
L
inks between pollution and health are hardly doubted
since the disastrous great London Smog and similar
incidents, yet uncertainties remain about risks at lower
concentrations.1 There is also considerable debate about the
pollutants responsible for observed health effects. In the
recent decade much attention has been given to ambient
particles, often characterised by the concentration of PM10 or
PM2.5. NO2 is one of the major gaseous air pollutants, which
continues to raise concern, and it is one of the two pollutants
regulated by the European Union (PM10 being the other).
1
Though NO2 is related to combustion processes in general, in
outdoor urban environments, NO2 is considered a marker for
the complex of traffic related pollutants. NO2 characterises
the spatial variation of traffic related air pollution better than
PM10 or PM2.5, and observed health effects of urban air
pollution characterised by NO2 have extended from impair-
ment of lung function growth up to premature respiratory
death.2 3
Most research on NO2 and children’s health investigates
acute effects. Several studies of asthmatic children found
NO2 related increases in attacks.
4–7 Some found associations
with other symptoms, but no asthma exacerbation.8 9 The
large PEACE study found no consistent NO2 effects on
respiratory symptoms or lung function.10 Several studies
found effects of other pollutants, but not NO2.
11–13
Within the literature from cross sectional studies, NO2 is
most clearly linked to cough, with consistent reports of
positive (if sometimes weak) associations.14–16 Slightly less
evidence is found overall for an association with bronchitis,
with Peters reporting a weak negative association, while
others show evidence (mostly weak) of a positive associa-
tion.14–17 Estimates of associations with asthma and wheeze
have been small and therefore, although varying in direction,
not inconsistent with each other.14–20 Gauderman reports
associations between asthma and measured NO2, and
between asthma and residence close to freeways, where
traffic levels are extremely high, but no association with
residence close to ordinary roads.21
In the atmosphere, NO2 is correlated with other pollutants
including PM10 and PM2.5, because of similar sources.
Pollutants’ independent effects are infrequently reported,
because of their intercorrelations. Fusco found some inde-
pendent NO2 effect on acute respiratory infections.
22 Braga
found independent PM10 effects only.
23 Some reported NO2
effects may be due to associations with other pollutants such
as ultrafine particles or diesel soot.
The Pollution and the Young (PATY) project assembled
health and exposure data for 58 561 children, from compar-
able cross sectional studies conducted in 12 countries.
Pooling original data allows harmonisation of analysis,
pursuit of research questions not addressed originally, and
inclusion of unpublished studies. Here we examine associa-
tions between NO2 and symptoms, in those PATY studies
with NO2 exposure data: 23 955 children aged 6–12, from five
countries. We present results from single- and multipollutant
models, exploiting the opportunity this pooled study gives to
attempt to assess effects of NO2, adjusted for other major
pollutants (SO2 and PM10). We further make use of the large
dataset to assess effect modification with more precision than
single studies.
METHODS
Study subjects and study design
Cross sectional studies were sought which: assessed respira-
tory symptoms and individual risk factors by questionnaire,
included cough and wheeze as outcomes, and allowed
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calculation of annual mean particulate matter measures by
study area. Table 1 describes the studies contributing to this
paper, detailed in individual reports.2 24–27
Eleven comparable outcomes were identified: wheeze in
last year, asthma ever, bronchitis in last year, phlegm,
nocturnal dry cough in last year, morning cough in last year,
‘‘sensitivity to inhaled allergens’’, hay fever ever, itchy rash
ever, ‘‘woken by wheeze in last year’’ and ‘‘allergic to pets’’.
Full wordings have been reported previously.28
The exposure of interest for each child was the annual
mean level of NO2 in the corresponding study area.
Exposure assessment methods
NO2 exposure was assessed by measurements at fixed
ambient monitoring sites. In Austria, NO2 concentration
data from eight monitoring stations across the city of Linz
were obtained from the routine network operated by the
State of Oberoestereich (OOE Luftmessnetz). NO2 is mea-
sured with continuous chemiluminescence monitors. In
Switzerland, averages were taken of existing passive sampler
measurements from each community.24 Measurements were
made within the other studies themselves, using passive
samplers. Italian and Dutch measurements were school
based.26 Russian measurements were performed at a central
site per area. Arithmetic annual means were calculated.
Using standard questionnaires, monitoring sites and sam-
pling/analysis methods were assessed.
Analysis
A two-stage approach was used. First, study-specific NO2
effects were estimated using logistic regression, with area-
level random intercept. In stage two, these estimates and
standard errors were entered into a meta-analysis, obtaining
a mean estimate, and a measure and Cochran x2 test of
heterogeneity. Study-specific effects are assumed to follow a
random distribution about a mean. Estimation of this mean
(and confidence interval) takes into account both between-
study variation in effects and uncertainty (due to sampling
variability) of study-specific estimates.29 Analyses were done
in STATA v8 (Stata Corp, College Station, TX, USA). Odds
ratios are reported per 10 mg/m3 increase in NO2.
We controlled for age, sex, maternal education, paternal
education, household crowding, current parental smoking,
mother smoking during pregnancy, gas cooking, unvented
gas/oil/kerosene heater, mould, nationality, birth order, and
‘‘ever had a pet’’. Additional models adjusted for PM10 and
(separately) SO2. Parental illnesses may be a confounder, but
over adjustment can occur, since the exposure of interest
could affect both children and parents. We tested robustness
of results to controlling for season of questionnaire, parental
illness, and differences in response rates per study area. We
also tested for effect modification by sex, age, and (since
these illnesses may have a strong genetic component) by
parental asthma or allergy.30
Meta-regressions assessed associations between study-
specific estimates and study characteristics. These potential
sources of heterogeneity between estimates were: study
period; between-city, within-city, or mixed design; location
of monitoring station; proportion of younger children (6–8);
questionnaire date variability across study areas; high
response rate (80+%); response rate variability across study
areas.
Individual PATY studies measured different combinations
of pollutants, which meant dropping some studies in multi-
pollutant analyses. We present single pollutant results from
the full set of five studies, and consider these the ‘‘best
estimates’’ of unadjusted effects (that is, unadjusted for other
pollutants). Within the smaller subset of studies with data
available on a second pollutant, we compare results from
one- and two-pollutant models, to show the degree of
uncontrolled confounding in the single-pollutant model.
We do not attempt a three-pollutant model, since a
maximum of three studies (only two or one for some
outcomes) would be included. We maintain our focus here
on associations with NO2. However, we include mean odds
ratios for PM10 and SO2 to aid the interpretation of results
from two-pollutant models.
RESULTS
Study areas in the Netherlands, Austria, and Russia had the
least variability in NO2 levels (and also in PM10 levels).
Russian study areas had the lowest recorded NO2, Italy the
highest and the most variable (fig 1). Russian study areas
had the highest, and most variable, levels of SO2 (table 1). Of
the three pollutants, mean PM10 levels varied the least across
the studies. Symptom prevalence was highest in Switzerland
Table 1 Details of component studies included in analyses
Study 10 cities, Russia Linz, Austria Scarpol, Switzerland 24 schools, Netherlands Sidria, Italy
Children, n 5559 4155 2783 2065 9393
Main age
range
8–12 6–8 6–12 7–12 6–10
Description of study areas
13 areas in 10 towns
of differing size (the
largest Ekaterinburg)
and industrialisation
Schools assigned to 8
monitors in the city of Linz
10 communities ranging
from major cities (Bern,
Geneva, Zu¨rich) to small
towns
24 schools located within
400 m of freeways, in 19
towns in mid/west
Netherlands
46 schools, in 28 areas within
1 km of a monitor in 22 towns,
from major cities (eg Rome,
Turin) to small towns.
Main questionnaire period
Apr–May 99 Jan 96–Dec 98 Oct 92–Mar 93 Apr 97–Jul 98 Oct 94–Mar 95
Range of response rates across study areas (%)
91–100 96–100 37–91 40–86 91–100
Time period of exposure data
Nov 98–Nov 99 Continuous data from 96–981992 April 97–May 98 1 Oct 93–30 Sept 94
Site of monitoring stations
Background Background Background/traffic Traffic Background/traffic
Mean NO2 exposure (min-max) mg/m
3
19.47 (12.45–34.71) 25.91 (20.25–31.25)* 31.60 (16.00–50.00) 34.81 (26.79–44.38) 52.04 (14.00–93.00)
Mean PM10 exposure (min–max) mg/m
3
24.46 (20.47–28.40) 32.14 (25.00–37.43)* 22.30 (10.00–33.00) 34.15 (30.28–38.86) NA
Mean SO2 exposure (min–max) mg/m
3
26.27 (6.68–64.93) 7.31 (4.98–10.88) 10.56 (2.00–23.00) NA 13.00 (2.00–32.00)
*For the 3 year Austria study: mean NO2 and range, across areas, of area-level means of three annual measures.
Not all studies measured all pollutants.
NA, not applicable.
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and the Netherlands (and correspondingly more variable)
(table 2). Response rates varied between study areas (table 1).
All area level response rates were above 90% in Austria,
Russia, and Italy, and more variable in the Swiss and Dutch
studies.
Single-pollutant models
Figure 2 shows study-specific and mean odds ratios. Dutch
estimates were often the largest, those from Italy the
smallest.
No strong patterns of association were seen between NO2
and asthma or bronchitis. Study-specific odds ratios were on
average small (with exceptions), spread above and below 1,
mean estimates essentially null (fig 2, table 3). Similar
pictures were seen for wheeze and ‘‘woken by wheeze’’, though
here study-specific results were larger, and heterogeneous.
Nocturnal cough estimates were also heterogeneous.
For phlegm, hay fever, and ‘‘itchy rash’’, estimates were
predominantly above one, though some very small.
Stronger consistent associations were seen with morning
cough, allergy to pets, and ‘‘sensitivity to inhaled allergens’’, all
with mean odds ratios around 1.14. For the latter, there was
evidence of heterogeneity within this (entirely positive) set of
results.
The Dutch, Swiss, and Russian studies analysed their data
originally.22 25 26 The PATY results agreed closely with the
original Dutch and Russian results, though original Swiss
results for bronchitis (controlling for fog) were stronger.
Two-pollutant models
Correlation coefficients between NO2 and PM10 ranged from
0.48 in the Netherlands to 0.95 in Switzerland, with a mean
of 0.74. For NO2 and SO2 they ranged from20.07 in Russia to
0.84 in Switzerland, 0.47 overall.
Controlling for SO2 changed NO2 effect estimates little
(table 4). Confounding, inconsistent in direction, was
confined largely to Swiss results. The largest change was
for bronchitis, the Swiss NO2 estimate reducing on adjust-
ment from 1.14 (0.84–1.55) to 0.68 (0.46–1.01). Morning
cough and ‘‘sensitivity to inhaled allergens’’ results were
unaffected. For ‘‘allergy to pets’’, while the confidence
interval widened, the mean estimate was unchanged.
Heterogeneity between results tended not to decrease after
adjusting for SO2. A link was seen between SO2 and ‘‘itchy
rash’’, with an adjusted mean odds ratio of 1.11 (1.01–1.23).
Other associations with SO2 (apart from the mean NO2
adjusted estimate for bronchitis, driven by a large effect in
the Swiss study) appeared generally weak, or reduced by
controlling for NO2.
PM10 proved a greater confounder, though direction was
not consistent across studies. Swiss NO2 effect estimates
(generally small) increased on adjustment. In the other
studies they were mainly reduced. On adjusting for PM10,
some mean estimates were robust or increased, particularly
for itchy rash, ‘‘woken by wheeze’’, allergy to pets and
‘‘sensitivity to inhaled allergens’’. However, adjusting for
PM10 reduced other estimates, notably for morning cough.
Heterogeneity tended to decrease (though not always) on
controlling for PM10. For example, among studies with PM10
data, I2, an estimate of that percentage of between study
difference related to heterogeneity (and not chance), reduced
from 54% to 0% for woken by wheeze, and 64% to 0% for
sensitivity to inhaled allergens.31 For phlegm and itchy rash
however, heterogeneity increased on adjustment for PM10. For
PM10, a link (based on only two studies) was seen with
phlegm, and raised risks—though not statistically signifi-
cant—with bronchitis and morning cough.
Study period appeared related to between-study hetero-
geneity. For nine outcomes, mean estimates from pre-1995
studies (Italy, Switzerland) were lower than for later studies.
The mean odds ratio for ‘‘sensitivity to inhaled allergens’’ was
1.01 (0.99–1.05) among earlier studies, 1.26 (1.11–1.43)
among later studies. Higher mean estimates tended to relate
to lower response rates (the Netherlands, Switzerland), to
between-area variability in response rates (primarily the
Netherlands, Switzerland), and to studies with monitoring
sites close to traffic (the Netherlands only). All these
Figure 1 NO2 measures (mg/m
3) per study area, within each country
(averaged across three years, for Austria).
Table 2 Prevalences of the 11 outcomes
Study
Prevalence within each study (%)
Standard deviation of area-level prevalences within study (%)
Wheeze Asthma Bronchitis Phlegm
Nocturnal
cough
Morning
cough
Sensitivity to
inhaled
allergens Hay fever Itchy rash
Woken by
wheeze
Allergy to
pets
Russia 13.40 1.88 14.72 7.15 11.35 6.44 1.21 4.36
2.6 1.1 3.7 1.7 2.7 2.4 1.0 1.2
Austria 13.55 8.59 10.42 5.30 12.78 5.24 8.17 5.81
2.1 3.5 2.1 1.4 2.5 2.1 2.1 1.6
Switzerland 10.37 8.98 18.25 21.54 11.90 13.73 10.15 13.29 4.64 4.56
2.1 2.2 7.8 9.8 4.1 2.1 2.5 2.5 1.3 1.2
Netherlands 9.54 8.14 7.92 9.54 21.58 15.22 7.19 22.26 4.93 9.30
3.6 4.1 3.7 4.1 6.5 5.7 3.2 5.3 2.4 4.1
Italy 6.72 9.00 12.43 5.53 15.73 10.92 7.81 14.16 1.82 1.82
1.2 2.5 4.4 1.6 2.5 2.2 2.3 2.8 1.0 1.1
Gaps occur where outcomes were not measured by all studies.
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differences are perhaps driven by high Dutch estimates and/
or low Italian estimates, potential causes thus remaining
indistinguishable.
Sensitivity analyses
Inclusion of response rate as a potential confounder did not
affect effect estimates. Mean effect estimates for sensitivity to
inhaled allergens changed from 1.13 (1.01–1.26) to 1.12
(1.00–1.25) after including response rate. Season of ques-
tionnaire was not related to reported illness, and did not
confound associations between NO2 and symptoms (data not
shown). Removing two traffic sites from the Austrian and
Swiss data sets (which probably provide exposure estimates
that are less comparable to the other sites in these studies),
made small, non-significant changes to the estimates for
some outcomes (others remained unchanged) in those
countries: mean estimates for sensitivity to inhaled allergens,
morning cough, and allergy to pets were slightly reduced, to
Figure 2 Forest plots of study-specific odds ratios, and mean odds ratios, for effects of NO2 on respiratory symptoms. Odds ratios (per 10 mg/m
3
increase in NO2) are from single-pollutant models, but adjusted for individual risk factors. Vertical line indicates null (odds ratio of 1). Horizontal lines
represent 95% confidence intervals of estimates. Diamond shape at bottom indicates position, and confidence interval, of the mean of the estimates.
Table 3 Mean odds ratios (per 10 mg/m3 increase in
NO2) from single-pollutant model, all available studies
Studies, n
Odds ratio (95% confidence
interval)
Wheeze 5 1.01 (0.93–1.10)H
Asthma 5 1.02 (0.94–1.09)
Bronchitis 4 0.99 (0.88–1.12)
Phlegm 3 1.05 (0.95–1.17)
Nocturnal cough 4 1.13 (0.94–1.35)H
Morning cough 3 1.15 (1.01–1.30)
Sensitivity to inhaled
allergens
5 1.13 (1.01–1.26)H
Hay fever 5 1.04 (0.98–1.11)
Itchy rash 4 1.05 (0.98–1.12)
Woken by wheeze 4 1.06 (0.89–1.26)H
Allergy to pets 4 1.14 (0.99–1.31)
‘‘H’’ indicates heterogeneity between study-specific results (p,0.10).
NO2 and children’s respiratory symptoms 831
www.occenvmed.com
1.11 (0.99–1.24), 1.13 (0.99–1.29), and 1.11 (0.97–1.28)
respectively.
Effect modification
Table 5 shows odds ratios for associations between NO2 and
sensitivity to inhaled allergens (the variable with a significant
main effect), for children categorised by potential effect
modifiers. Effect estimates were consistently higher in the
older children, though the difference with the younger
children was of borderline significance only (p = 0.08).
Similar non-significant differences were found for hay fever
and pet allergy (table 6). Effect estimates were higher in boys
than in girls, but the difference between boys and girls was
highly non-significant (p = 0.43) and not supported consis-
tently by other allergy outcomes (table 6). Parental health
was related to the child’s health, but neither greatly
confounded nor modified associations between child’s illness
and NO2 (table 6).
DISCUSSION
We found no overall evidence of associations between
ambient NO2 and doctor diagnosis of bronchitis or asthma,
nor of key symptoms of asthma such as wheeze being related
to NO2. A weak but consistent positive association was found
for reported allergic symptoms, especially ‘‘allergy to pets’’
and ‘‘sensitivity to inhaled allergens’’. These two allergy
results are not independent, as the latter may include allergy
to animal dander.
Our findings match reports (from single pollutant models)
of positive associations between NO2 and cough.
14–16 Our
asthma results—small, statistically consistent, showing no
overall association—also reflect previous findings.14–19 Our
results do not support the overall (weak) positive association
with bronchitis14–17 Nor do they support negative associations
with hay fever.14 18 Our most robust associations were with
the allergy symptoms, where the literature is sparser. Kramer
reports associations between children’s sensitisation to
allergens and playing in traffic dense areas, while two other
studies find no associations between NO2 and allergic
sensitisation.15 32 33 We have analysed parent-reported allergy
only, an imperfect marker of actual allergic status. Braun
found weaker associations between traffic exposure and
questionnaire allergy responses than between traffic and
tested atopy, and found questionnaire rhinitis responses
highly specific but not highly sensitive.34 35 Within PATY’s
Dutch study, a similar comparison showed closer agree-
ment.26 Results for sensitivity to inhaled allergens and allergy
to pets were very similar. Odds ratios for hay fever were also
predominantly positive, albeit smaller. This consistency
across related questions and across studies supports that this
association is not a chance finding among the many
evaluated outcome variables. It seems unlikely that informa-
tion bias explains the findings for allergy, because parents
would probably report asthma/asthma symptoms more than
allergy symptoms, if awareness of exposure played a role.
Pooling of studies has both advantages and disadvantages
and these may have contributed to the lack of associations for
key respiratory outcomes and to the heterogeneity of results
across studies. Advantages include the large number of
children in the study and the range in exposure. Confidence
intervals were generally small. A major concern with meta-
analyses in general is comparability of studies and this
applies to our study as well. Because the same statistical
model and the same confounder model was used for all
Table 4 Mean odds ratios (per 10 mg/m3 increase in pollutant) within subset of studies having both pollutant measures
Studies, n
Odds ratio (95% confidence interval)
NO2 Second pollutant
Single-pollutant model Two-pollutant model Single-pollutant model Two-pollutant model
Wheeze
Studies with SO2 data 4 0.99 (0.93–1.05) 0.99 (0.89–1.10)
H 1.03 (0.96–1.11) 1.08 (1.02–1.13)
Studies with PM10 data 4 1.05 (0.94–1.18) 1.10 (0.98–1.24) 1.01 (0.87–1.17) 0.98 (0.80–1.20)
Asthma
Studies with SO2 data 4 1.01 (0.93–1.10) 1.03 (0.92–1.14) 0.98 (0.88–1.09) 0.94 (0.82–1.08)
Studies with PM10 data 4 1.03 (0.89–1.20) 1.03 (0.84–1.26) 1.02 (0.85–1.23) 1.11 (0.84–1.47)
Bronchitis
Studies with SO2 data 3 1.02 (0.86–1.22)
H 0.89 (0.76–1.04) 1.02 (0.92–1.13) 1.41 (0.87–2.28)H
Studies with PM10 data 3 1.05 (0.82–1.33) 0.99 (0.67–1.46) 1.35 (0.96–1.91) 1.49 (0.85–2.61)
Phlegm
Studies with SO2 data 2 1.02 (0.96–1.07) 1.01 (0.94–1.08) 1.01 (0.95–1.08) 1.01 (0.94–1.09)
Studies with PM10 data 2 1.14 (0.95–1.37) 1.06 (0.75–1.51) 1.55 (1.11–2.18) 1.55 (1.01–2.38)
Nocturnal cough
Studies with SO2 data 3 1.15 (0.89–1.49)
H 1.15 (0.86–1.52)H 1.19 (0.86–1.66)H 1.03 (0.79–1.34)
Studies with PM10 data 3 1.19 (0.94–1.51)
H 1.21 (0.94–1.56) 1.14 (0.68–1.91)H 0.79 (0.53–1.19)
Morning cough
Studies with SO2 data 3 1.16 (1.02–1.33) 1.20 (1.03–1.40) 0.99 (0.89–1.10) 0.98 (0.88–1.08)
Studies with PM10 data 3 1.15 (1.01–1.30) 1.04 (0.90–1.20) 1.42 (1.04–1.92) 1.36 (0.87–2.13)
Sensitivity to inhaled allergens
Studies with SO2 data 4 1.07 (0.97–1.19)
H 1.10 (0.96–1.27)H 1.01 (0.94–1.08) 0.99 (0.90–1.09)
Studies with PM10 data 4 1.19 (1.04–1.36) 1.24 (1.08–1.43) 1.18 (0.99–1.41) 0.98 (0.70–1.38)
Hay fever
Studies with SO2 data 4 1.03 (0.97–1.10) 1.02 (0.94–1.11) 1.05 (0.90–1.22) 1.03 (0.88–1.21)
Studies with PM10 data 4 1.04 (0.89–1.22) 1.03 (0.83–1.28) 1.22 (0.84–1.76)
H 1.18 (0.70–1.97)
Itchy rash
Studies with SO2 data 3 1.01 (0.98–1.05) 0.98 (0.93–1.03) 1.08 (1.00–1.15) 1.11 (1.01–1.23)
Studies with PM10 data 3 1.11 (1.01–1.22) 1.20 (0.90–1.60)
H 1.18 (0.94–1.50) 0.91 (0.48–1.71)H
Woken by wheeze
Studies with SO2 data 3 0.98 (0.87–1.11) 0.95 (0.76–1.19)
H 1.05 (0.89–1.24) 1.14 (0.94–1.38)
Studies with PM10 data 3 1.15 (0.92–1.42) 1.26 (1.01–1.57) 1.14 (0.77–1.68) 0.92 (0.56–1.51)
Allergy to pets
Studies with SO2 data 3 1.06 (0.97–1.15) 1.05 (0.86–1.30) 1.19 (1.01–1.40) 1.08 (0.70–1.66)
Studies with PM10 data 3 1.22 (1.02–1.45) 1.38 (1.00–1.90) 1.25 (0.92–1.70) 0.87 (0.42–1.80)
H
Columns 3 and 4 compare mean estimates of NO2 effects from one- and two-pollutant models, in studies with SO2 data (1st row), or with PM10 data (2nd row).
Columns 5 and 6 similarly compare estimates for the corresponding second pollutant. ‘‘H’’ indicates heterogeneity between study-specific results (p,0.10).
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studies, the current analyses will be more comparable than a
traditional meta-analysis where only published effect esti-
mate are compared across studies. As these studies were
initiated independently, they sometimes differed in design,
wording of symptoms, and exposure assessment methods.
We assessed symptom and confounder questionnaires to
extract the symptoms thought to be most comparable across
studies. We also assessed differences in exposure assessment.
All studies used well accepted methods for measurement of
NO2 and were able to assess average concentrations with
good precision. Much of the (systematic) differences in study
methodologies were taken care of by the design of the
analysis, specifically the analysis of associations per country,
followed by a formal meta-analysis, and the impact on results
of differences between studies was tested for. As the same
exposure variables are used for all symptoms, errors in
exposure assessment are an unlikely source of the pattern of
association seen in our study.
As the studies differed in geographical scale of the study
area, it is likely that contrasts in NO2 reflect different
pollution mixtures. In the Dutch and Austrian studies,
contrasts in NO2 are primarily due to local (traffic) sources.
In these studies, other primary pollutants such as diesel soot
or ultrafine particles probably have the same exposure
contrast as NO2. In the other studies, contrasts in NO2 are
largely due to differences in large scale background concen-
trations and urban/rural differences. In these studies,
contrasts in NO2 will be associated with contrasts in both
primary and secondary fine particles.
Confounding by unmeasured area related factors cannot be
discounted. Such a confounder should be strongly related
both to NO2 and the respiratory symptom, and so credibility
of observed associations is enhanced by being measured
across more areas, and by consistency across more studies.
Differing response rates between study areas could give rise
to bias but we found no confounding by response rate. If
parents with illness more frequently report their child’s
illness, and if this difference were more acute in more
polluted areas, this could give rise to a bias. Examining this in
the four available countries showed no evidence of greater
observed association between NO2 and sensitivity to inhaled
allergens among children with asthmatic parents.
We have reported all mean estimates, for completeness.
Where study specific results vary considerably (inverse and
positive), a mean estimate is not necessarily useful.
Otherwise, where heterogeneity is within a pattern of
predominantly or entirely positive estimates, the mean odds
ratio serves as a ‘‘best estimate’’ (the calculation of its
confidence interval taking account of heterogeneity between
estimates, as well as their individual uncertainties). The
distribution about this mean remains important.
NO2 concentrations were correlated with the concentration
of PM10 and SO2. Thus, some of the association with NO2
could actually be due to these pollutants or other unmea-
sured pollutants. We therefore performed two-pollutant
analyses. Both PM10 and NO2 showed initial associations
with morning cough. After mutual adjustment neither
estimate was statistically significant, though the PM10
estimate was considerably less reduced than that for NO2,
suggesting a stronger association. Associations between NO2
and the two allergy outcomes were unaffected by controlling
for PM10. Controlling for SO2 affected conclusions little. A
limitation of two-pollutant models was that correlations
between pollutants within countries were high, particularly
in the Swiss study. Studies with a higher correlation between
pollutants will have less weight in meta-analyses, because of
higher standard errors of the effect estimates. Indeed, we
observed that while individual study results sometimes
changed appreciably, the overall association was only mildly
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affected by inclusion of other pollutants. A more funda-
mental limitation is that two pollutants may actually be an
indicator for the same source, such that mutual adjustment
results in over-adjustment. This applies to the models
including PM10 and NO2, for which traffic is an important
source.
NO2 may be directly responsible for the observed associa-
tions or it may act as an indicator of traffic related air
pollutants for example diesel soot or ultrafine particles. The
available data do not allow us to distinguish between these
two options. While associations with NO2 remained after
adjusting for PM10, we did not have information available
about more specific indicators of particles from traffic—for
example, diesel soot, which has also been linked to increased
sensitisation to common allergens. Within PATY we did not
have consistent information about soot concentrations.
Several studies using controlled exposure to NO2 found it
could increase effects of allergens.36–38 A WHO working group
reported: ‘‘The mechanistic basis for these interactions has
not been elucidated. The studies might suggest that NO2 can
exhibit a ‘priming’ effect, by, for example, affecting epithelial
function.’’39 The group suggested that associations in
epidemiological studies are not primarily due to NO2 but to
other unmeasured traffic related pollutants or to secondary
pollutants.39
Effect modification
We found no consistent differences between effects in boys
and girls. Several previous studies reported greater NO2
effects in girls, though few of these reported on allergy.18 40–42
Peters found NO2 effects only in boys, not girls, while Shima
found no effect modification by sex, either for allergy or other
outcomes.16 17 Stratifiying by age, we found NO2 associations
with allergy to be stronger in older than younger children,
though evidence for effect modification was not strong.
Hirsch reports no effect modification by age, while Shima
shows increasing NO2 effects with age in boys, and decreasing
effects in girls, so that NO2 effects are greater in young girls
than boys, and greater in old boys than girls.15 17 In the PATY
data, effects increased with age for both sexes (data not
shown).
In summary, evidence for associations between NO2 and
respiratory symptoms was robust only for inhalation aller-
gies. The importance of this finding remains, as policies to
reduce traffic related air pollution will not result in rapid
reductions.
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